Another common way for NSCLC cells to acquire EGFR-TKI resistance is the epithelial-mesenchymal transition (EMT) where cells undergo a switch from being epithelial- to mesenchymal-like. This evidence concerns the gene EGFR and non-small cell lung carcinoma.